Figure 6 | Scientific Reports

Figure 6

From: Automated feature quantification of Lipiodol as imaging biomarker to predict therapeutic efficacy of conventional transarterial chemoembolization of liver cancer

Figure 6

Peripheral Lipiodol coverage. Peripheral coverage with Lipiodol is associated with increased response. On average, a 1% increase in peripheral coverage contributes to a − 0.62% reduction in viable tumor tissue. PR = partial response (based on quantitative European Association for the Study of the Liver (qEASL) tumor response criteria).

Back to article page